IMOV
BMY icon

Investment Management of Virginia’s Bristol-Myers Squibb BMY Stock Holding History

Investment Management of Virginia’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$11.1M Sell
160,742
-1,720
-1% -$121K 2.12% 8
2022
Q4 		$11.7M Sell
162,462
-1,276
-0.8% -$96.2K 2.29% 5
2022
Q3 		$11.6M Sell
163,738
-938
-0.6% -$68K 2.52% 3
2022
Q2 		$12.7M Sell
164,676
-1,672
-1% -$127K 2.61% 3
2022
Q1 		$12.1M Sell
166,348
-934
-0.6% -$62.7K 2.13% 8
2021
Q4 		$10.4M Sell
167,282
-660
-0.4% -$38.7K 1.68% 16
2021
Q3 		$9.94M Buy
167,942
+302
+0.2% +$19.9K 1.91% 10
2021
Q2 		$11.2M Sell
167,640
-1,543
-0.9% -$101K 2.16% 7
2021
Q1 		$10.7M Buy
169,183
+315
+0.2% +$19.6K 2.15% 7
2020
Q4 		$10.5M Sell
168,868
-2,163
-1% -$133K 2.28% 7
2020
Q3 		$10.3M Sell
171,031
-4,977
-3% -$300K 2.57% 5
2020
Q2 		$10.3M Sell
176,008
-1,616
-0.9% -$96.7K 2.58% 7
2020
Q1 		$9.9M Sell
177,624
-4,761
-3% -$291K 3% 4
2019
Q4 		$11.7M Buy
182,385
+8,221
+5% +$471K 2.68% 5
2019
Q3 		$8.83M Buy
174,164
+28,003
+19% +$1.32M 2.17% 8
2019
Q2 		$6.63M Buy
146,161
+25,647
+21% +$1.19M 1.59% 17
2019
Q1 		$5.75M Buy
120,514
+73,201
+155% +$3.65M 0.68% 50
2018
Q4 		$2.46M Buy
47,313
+17,235
+57% +$926K 0.64% 50
2018
Q3 		$1.87M Hold
30,078
– – 0.39% 73
2018
Q2 		$1.67M Buy
30,078
+1,393
+5% +$75.2K 0.37% 81
2018
Q1 		$1.81M Buy
28,685
+75
+0.3% +$4.83K 0.42% 77
2017
Q4 		$1.75M Sell
28,610
-279
-1% -$17.5K 0.42% 77
2017
Q3 		$1.84M Sell
28,889
-3,701
-11% -$216K 0.43% 68
2017
Q2 		$1.61M Buy
32,590
+3,711
+13% +$202K 0.39% 72
2017
Q1 		$1.57M Buy
28,879
+250
+0.9% +$13.7K 0.39% 73
2016
Q4 		$1.67M Buy
28,629
+21,558
+305% +$1.18M 0.4% 72
2016
Q3 		$382K Sell
7,071
-600
-8% -$38.5K 0.09% 125
2016
Q2 		$564K Sell
7,671
-400
-5% -$28.3K 0.14% 123
2016
Q1 		$516K Sell
8,071
-100
-1% -$6.31K 0.14% 123
2015
Q4 		$562K Hold
8,171
– – 0.15% 125
2015
Q3 		$484K Hold
8,171
– – 0.13% 132
2015
Q2 		$543K Sell
8,171
-500
-6% -$33K 0.13% 134
2015
Q1 		$560K Sell
8,671
-85
-1% -$5.32K 0.13% 128
2014
Q4 		$517K Sell
8,756
-300
-3% -$16.9K 0.11% 129
2014
Q3 		$464K Sell
9,056
-200
-2% -$9.99K 0.08% 128
2014
Q2 		$449K Hold
9,256
– – 0.07% 132
2014
Q1 		$481K Sell
9,256
-13,425
-59% -$714K 0.08% 137
2013
Q4 		$1.21M Sell
22,681
-19,720
-47% -$1M 0.2% 115
2013
Q3 		$1.96M Buy
42,401
+15
+0% +$658 0.38% 74
2013
Q2 		$1.89M Buy
+42,386
New +$1.84M 0.42% 68

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Investment Management of Virginia's BMY Position: Q1 2023 in Review

Investment Management of Virginia reduced its Bristol-Myers Squibb (BMY) stake by 1.1% in Q1 2023, selling an estimated $121K and leaving 160,742 shares worth $11.1M. The position accounts for 2.12% of the portfolio, ranked #8.

Investment Management of Virginia first reported a position in BMY in Q2 2013 and has held it in 40 quarters since. The position peaked at $12.7M in Q2 2022. 2,542 funds tracked by Wall St. Rank hold BMY as of Q1 2023.

  • Investment Management of Virginia held 160,742 shares of Bristol-Myers Squibb worth $11.1M as of Q1 2023.
  • Investment Management of Virginia sold 1,720 Bristol-Myers Squibb shares in Q1 2023, an estimated $121K.
  • Bristol-Myers Squibb made up 2.12% of Investment Management of Virginia's portfolio in Q1 2023, its #8 holding.
  • Investment Management of Virginia first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 40 quarters since.
  • Investment Management of Virginia's Bristol-Myers Squibb position peaked at $12.7M in Q2 2022.
  • 2,542 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2023.

Based on Investment Management of Virginia's 13F filing for Q1 2023, filed 26 Apr 2023.